Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thymoglobulin”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04046549
What this trial is testing

Evaluate the Safety and Efficacy of Dual Costimulation Blockade With VIB4920 and Belatacept for Prophylaxis of Allograft Rejection in Adults Receiving a Kidney Transplant

Who this might be right for
AllograftsRejection; Transplant, KidneyTransplant Rejection+1 more
Amgen 25
Early research (Phase 1)Study completedNCT00545519
What this trial is testing

A Phase I Study Of Thymoglobulin In Patients With Relapsed Or Refractory Multiple Myeloma

Who this might be right for
Relapsed Or Refractory Multiple Myeloma
Washington University School of Medicine 6
Post-approval studies (Phase 4)Ended earlyNCT00596947
What this trial is testing

Prednisone Withdrawal Versus Prednisone Maintenance After Kidney Transplant

Who this might be right for
Transplants and Implants
University of Pennsylvania 18
Post-approval studies (Phase 4)Study completedNCT01729494
What this trial is testing

Belatacept Early Steroid Withdrawal Trial

Who this might be right for
Renal Transplantation
University of Cincinnati 316
Not applicableStudy completedNCT01976390
What this trial is testing

Comparing Everolimus and Sirolimus in Renal Transplant Recipients

Who this might be right for
Renal Failure
Ohio State University 60
Post-approval studies (Phase 4)Study completedNCT00261820
What this trial is testing

Study Comparing Two Immunosuppressive Regimens in De Novo Renal Allograft Recipients

Who this might be right for
Graft RejectionKidney FailureKidney Transplantation
Wyeth is now a wholly owned subsidiary of Pfizer 160
Large-scale testing (Phase 3)Study completedNCT00354120
What this trial is testing

Thymoglobuline Versus Alemtuzumab in Patients Undergoing Allogeneic Transplant

Who this might be right for
Acute Myeloblastic LeukemiaLymphoblastic LeukemiaMyelodysplasia+3 more
Gruppo Italiano Trapianto di Midollo Osseo 121
Testing effectiveness (Phase 2)Study completedNCT00017550
What this trial is testing

Antithymocyte Globulin Compared With Supportive Care in Treating Patients With Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic Syndromes
Genzyme, a Sanofi Company
Not applicableEnded earlyNCT00235781
What this trial is testing

Single Dose Thymoglobulin for Induction in Adult Renal Allograft Recipients

Who this might be right for
Kidney Transplantation
Washington University School of Medicine 90
Large-scale testing (Phase 3)UnknownNCT01217723
What this trial is testing

Thymoglobulin in Unrelated Hematopoietic Progenitor Cell Transplantation

Who this might be right for
Hematologic Malignancies
McMaster University 198
Testing effectiveness (Phase 2)Study completedNCT00787761
What this trial is testing

Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer

Who this might be right for
Myeloproliferative DisordersKidney CancerLeukemia+4 more
Northside Hospital, Inc. 24
Early research (Phase 1)WithdrawnNCT00972101
What this trial is testing

Infusion of Expanded Cord Blood T Cells

Who this might be right for
Stem Cell TransplantationLeukemiaLymphoma+1 more
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT07508787
What this trial is testing

A Study Comparing Siplizumab With Rabbit Anti-Thymocyte Globulin to Help the Body Accept a Kidney Transplant

Who this might be right for
Renal Transplant Failure and Rejection
Nefro Avillion Clinical Development, LLC 120
Post-approval studies (Phase 4)Study completedNCT03006419
What this trial is testing

Basiliximab vs Low-dose Thymoglobulin Induction Therapy in Low Risk Kidney Transplant Patients

Who this might be right for
Kidney Transplant RejectionKidney Transplant; Complications
Coordinación de Investigación en Salud, Mexico 100
Testing effectiveness (Phase 2)Ended earlyNCT00593645
What this trial is testing

Clofarabine, Cytarabine, and Thymoglobulin for Allogeneic Transplantation

Who this might be right for
Myelodysplastic SyndromesAcute Myeloid Leukemia
Washington University School of Medicine 7
Not applicableStudy completedNCT01207141
What this trial is testing

RATG Induction and Tacrolimus Monotherapy in Pediatric Liver Transplantation

Who this might be right for
Liver TransplantationThymoglobulinRejection
University of Pittsburgh 110
Testing effectiveness (Phase 2)Ended earlyNCT00542828
What this trial is testing

Rabbit Anti-thymocyte Globulin in the Treatment of Patients With Low to Intermediate-1 Risk Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic Syndrome (MDS)
Genzyme, a Sanofi Company 16
Not applicableUnknownNCT00093587
What this trial is testing

Antithymocyte Globulin and Cyclosporine in Preventing Graft-Versus-Host Disease in Patients Undergoing Chemotherapy With or Without Radiation Therapy Followed By Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia

Who this might be right for
Graft Versus Host DiseaseLeukemia
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00944749
What this trial is testing

Horse ATG/CsA in Aplastic Anemia Patients Unresponsive to or With a Suboptimal Response to Rabbit ATG/CsA Treatment

Who this might be right for
Anemia, AplasticAnemia, Hypoplastic
National Heart, Lung, and Blood Institute (NHLBI) 23
Testing effectiveness (Phase 2)Study completedNCT00260689
What this trial is testing

Three Immunosuppressive Treatment Regimens for Severe Aplastic Anemia

Who this might be right for
ImmunosuppresionThrombocytopeniaPancytopenia+1 more
National Heart, Lung, and Blood Institute (NHLBI) 136
Next Page